Josep Oriola

2.3k total citations · 1 hit paper
77 papers, 1.8k citations indexed

About

Josep Oriola is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Josep Oriola has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in Josep Oriola's work include Thyroid Cancer Diagnosis and Treatment (14 papers), Pituitary Gland Disorders and Treatments (12 papers) and Growth Hormone and Insulin-like Growth Factors (11 papers). Josep Oriola is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (14 papers), Pituitary Gland Disorders and Treatments (12 papers) and Growth Hormone and Insulin-like Growth Factors (11 papers). Josep Oriola collaborates with scholars based in Spain, United States and Sweden. Josep Oriola's co-authors include Francisca Rivera, Manuel Palacı́n, António Zorzano, Marta Camps, Daniel Q. Bach, Bernhard Baumgartner, Martin D. Brand, Jorge Lloberas, Hubert Vidal and Rémi Rabasa‐Lhoret and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Josep Oriola

74 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism

2003 682 citations Daniel Q. Bach, Sara Pich et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Josep Oriola

Since Specialization

Citations

This map shows the geographic impact of Josep Oriola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Oriola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Oriola more than expected).

Fields of papers citing papers by Josep Oriola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Oriola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Oriola. The network helps show where Josep Oriola may publish in the future.

Co-authorship network of co-authors of Josep Oriola

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Oriola. A scholar is included among the top collaborators of Josep Oriola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Oriola. Josep Oriola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases 2025 ·The Journal of Clinical Endocrinology & Metabolism ·Nuria Valdés, (unknown), (unknown), María Calatayud, Cristina Lamas, Marta Araujo‐Castro, Rosa Martı́nez, Josep Oriola, (unknown), (unknown), Victoria Alcázar, Julia Sastre, María Isabel Del Olmo-García, E. Boix, (unknown), (unknown), Sílvia Pérez-Fernández, María‐Dolores Chiara, Anna Casteràs	1
2	Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study 2024 ·Frontiers in Endocrinology ·Nuria Valdés, (unknown), (unknown), María Calatayud, Cristina Lamas, Marta Araujo‐Castro, Cristina Álvarez‐Escolá, José A. Díaz, Victoria Alcázar, Julia Sastre, Rosa Martı́nez, Josep Oriola, Miguel Paja, (unknown), Isabel Salinas, (unknown), Elena Navarro, María‐Dolores Chiara, Luís Castaño, Anna Casteràs	3
3	Implementation of Exome Sequencing in Clinical Practice for Neurological Disorders 2023 ·Genes ·María Isabel Álvarez‐Mora, Laia Rodríguez‐Revenga, Meritxell Jodar, Míriam Potrony, Aurora Sánchez, Célia Bádenas, Josep Oriola, José Luis Villanueva‐Cañas, Esteban Muñoz, Francesc Valldeoriola, Anna Maria Novella Càmara, Yaroslau Compta, Mar Carreño, Marı́a José Martı́, Raquel Sánchez‐Valle, Irene Madrigal	4
4	Assessment of aggressive bladder cancer mutations in plasma cell-free DNA 2023 ·Frontiers in Oncology ·(unknown), Mercedes Ingelmo‐Torres, Josep Oriola, (unknown), Leonardo Rodríguez‐Carunchio, Sandra Herránz, Begoña Mellado, Antonio Alcaraz, Laura Izquierdo, Lourdes Mengual	2
5	Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer 2020 ·Hormones and Cancer ·(unknown), Célia Bádenas, Jordi L. Reverter, (unknown), Míriam Potrony, Mireia Mora, Irene Halperín, Josep Oriola	11
6	MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes 2019 ·Endocrine Connections ·Cristina Lamas, Elena Navarro, Anna Casteràs, (unknown), Victoria Alcázar, María Calatayud, Cristina Álvarez‐Escolá, Julia Sastre, E. Boix, Lluís Forga, (unknown), Josep Oriola, Jordi Mesa, Nuria Valdés	16
7	Functional characterization of MODY2 mutations in the nuclear export signal of glucokinase 2018 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), (unknown), Josep Oriola, Olivier Vincent, María‐Ángeles Navas	4
8	Lack of Glibenclamide Response in a Case of Permanent Neonatal Diabetes Caused by Incomplete Inactivation of Glucokinase 2014 ·JIMD Reports ·Josep Oriola, (unknown), (unknown), (unknown), (unknown), Olivier Vincent, María‐Ángeles Navas	4
9	Prevalence of germline mutations of AIP gene in sporadic aggressive somatotropinomas 2011 ·Manel Puig‐Domingo, Josep Oriola, Irene Halperín, María I. Mora, (unknown), (unknown), Cristina Álvarez‐Escolá, (unknown), Ignacio Bernabéu, Mónica Marazuela	1
10	Association of p.His38Leu, a Rare <i>CYP21A2</i> Mutation, with the Classical Simple Virilizing Phenotype of 21-Hydroxylase Deficiency in a 6-Year-Old Boy 2011 ·Hormone Research in Paediatrics ·Josep Oriola, (unknown), Carme Valls, Lourdes Ibáñez	1
11	Aging phenotype and its relationship with IGF-I gene promoter polymorphisms in elderly people living in Catalonia 2011 ·Growth Hormone & IGF Research ·Mireia Mora, (unknown), Mateu Serra‐Prat, Elísabet Palomera, (unknown), Josep Oriola, Manel Puig‐Domingo	13
12	Hiperplasia suprarrenal congénita por déficit de 21-hidroxilasa. ¿Cuándo es necesario conocer el genotipo? 2005 ·Endocrinología y Nutrición ·Josep Oriola	1
13	Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism breakdown → 2003 ·Journal of Biological Chemistry ·Daniel Q. Bach, Sara Pich, Francesc X. Soriano, Nathalie Véga, Bernhard Baumgartner, Josep Oriola, Jens R. Daugaard, Jorge Lloberas, Marta Camps, Juleen R. Zierath, Rémi Rabasa‐Lhoret, Harriet Wallberg‐Henriksson, Martine Laville, Manuel Palacı́n, Hubert Vidal, Francisca Rivera, Martin D. Brand, António Zorzano	682
14	Características clínicas, metabólicas, inmunológicas y genotípicas de un grupo de adolescentes y adultos con diabetes mellitus tipo 1A. Inicio y pronóstico a corto plazo 2003 ·Medicina Clínica ·Eva Aguilera, Mónica Recasens, Rosa Morı́nigo, Roser Casamitjana, Josep Oriola, Guadalupe Ercilla, Ignacio Conget	1
15	Screening of selected genomic areas potentially involved in thyroid neoplasms 2001 ·European Journal of Cancer ·Josep Oriola, Irene Halperín, Carme Mallofré, Jordi Muntané, (unknown), (unknown)	13
16	Lack of association between ACE gene polymorphism and left ventricular hypertrophy in essential hypertension 2000 ·Journal of Human Hypertension ·Elisenda Gómez-Angelats, Àngels Sierra, Montserrat Enjuto, Cristina Sierra, Josep Oriola, Antonio Francino, (unknown), Esteban Poch, António Coca	18
17	Postrenal transplant erythrocytosis and insertion/deletion polymorphism of the angiotensin converting enzyme gene 1999 ·Transplantation Proceedings ·José‐Vicente Torregrosa, Esteban Poch, Josep Oriola, Josep M. Campistol, Frederic Cofán, Pablo Íñigo, F Oppenheimer	3
18	Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis 1998 ·Kidney International ·Patricia Fernández‐Llama, Esteban Poch, Josep Oriola, A Botey, Elisabet Coll, Alejandro Darnell, Francisca Rivera, Luis Revert	68
19	Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites 1995 ·Gastroenterology ·(unknown), Wladimiro Jiménez, Santiago Lamas, Marta Bosch‐Marcé, Josep Oriola, Joan Clària, Vicente Arroyo, Francisca Rivera, Joan Rodés	47
20	Rsal Polymorphism of the human growth hormone gene (GH1) 1991 ·Nucleic Acids Research ·Josep Oriola, Roser Casamitjana, (unknown), (unknown), Matilde Romero, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact